Tango Therapeutics

Tango is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer.

Business Model: Non-Profit

Revenue: $24.2M

Employees: 51-200

Detailed Tango Therapeutics Information

Geographic Data

Tango Therapeutics headquarters map

Address: 100 Binney Street

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$186M

Raised Total:

$165M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Tango is a Massachusetts-based biotechnology company that develops and commercializes novel therapeutics for the treatment of cancer.

Contact Phone:
+18573204900

Contact Email:

Tango Therapeutics went public on 8/11/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
8/11/2021

Ticker Symbol:
TNGX

Amount Raised:
$353M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
3/2017 Series A 1 $55M Third Rock Ventures
Third Rock Ventures
8/2021 Post-IPO Equity $0 Gilead Sciences
Avoro Capital Advisors
Bain Capital Life Sciences
Boxer Capital
Casdin Capital
Cormorant Asset Management
EcoR1 Capital
Farallon Capital Management
Fidelity Management and Research Company
Foresite Capital
Janus Henderson Investors
Logos Capital
RA Capital Management
Samsara BioCapital
Southpoint Capital Advisors
Surveyor Capital
Woodline Partners
Gilead Sciences
Avoro Capital Advisors
Bain Capital Life Sciences
Boxer Capital
Casdin Capital
Cormorant Asset Management
EcoR1 Capital
Farallon Capital Management
Fidelity Management and Research Company
Foresite Capital
Janus Henderson Investors
Logos Capital
RA Capital Management
Samsara BioCapital
Southpoint Capital Advisors
Surveyor Capital
Woodline Partners
4/2020 Series B 3 $60M Boxer Capital
Cormorant Asset Management
Casdin Capital
Boxer Capital
8/2020 Venture Round 4 $50M Casdin Capital
Gilead Sciences
Cormorant Asset Management
Boxer Capital
Casdin Capital
8/2021 Post-IPO Equity 17 $186M Avoro Capital Advisors
Bain Capital Life Sciences
Boxer Capital
Casdin Capital
Cormorant Asset Management
EcoR1 Capital
Farallon Capital Management
Fidelity Management and Research Company
Foresite Capital
Gilead Sciences
Janus Henderson Investors
Logos Capital
RA Capital Management
Samsara BioCapital
Southpoint Capital Advisors
Surveyor Capital
Woodline Partners
Avoro Capital Advisors
Bain Capital Life Sciences
Boxer Capital
Casdin Capital
Cormorant Asset Management
EcoR1 Capital
Farallon Capital Management
Fidelity Management and Research Company
Foresite Capital
Gilead Sciences
Janus Henderson Investors
Logos Capital
RA Capital Management
Samsara BioCapital
Southpoint Capital Advisors
Surveyor Capital
Woodline Partners
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research